117 related articles for article (PubMed ID: 9756399)
1. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Cabrera T; Collado A; Fernandez MA; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1998 Aug; 52(2):114-23. PubMed ID: 9756399
[TBL] [Abstract][Full Text] [Related]
2. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
3. High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
Hum Immunol; 1996 Oct; 50(2):127-34. PubMed ID: 8891736
[TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
5. HLA class I expression in bladder carcinomas.
Cabrera T; Pedrajas G; Cozar JM; Garrido A; Vicente J; Tallada M; Garrido F
Tissue Antigens; 2003 Oct; 62(4):324-7. PubMed ID: 12974799
[TBL] [Abstract][Full Text] [Related]
6. High frequency of HLA-B44 allelic losses in human solid tumors.
Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
[TBL] [Abstract][Full Text] [Related]
7. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
[TBL] [Abstract][Full Text] [Related]
8. High-resolution analysis of HLA class I alterations in colorectal cancer.
Dierssen JW; de Miranda NF; Mulder A; van Puijenbroek M; Verduyn W; Claas FH; van de Velde CJ; Jan Fleuren G; Cornelisse CJ; Corver WE; Morreau H
BMC Cancer; 2006 Oct; 6():233. PubMed ID: 17014712
[TBL] [Abstract][Full Text] [Related]
9. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
Rodriguez T; Aptsiauri N; Méndez R; Jimenez P; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2007 Apr; 69 Suppl 1():259-63. PubMed ID: 17445215
[TBL] [Abstract][Full Text] [Related]
11. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
Cabrera CM; López-Nevot MA; Jiménez P; Garrido F
Int J Cancer; 2005 Feb; 113(4):611-8. PubMed ID: 15455354
[TBL] [Abstract][Full Text] [Related]
13. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
Koopman LA; Mulder A; Corver WE; Anholts JD; Giphart MJ; Claas FH; Fleuren GJ
Tissue Antigens; 1998 Jun; 51(6):623-36. PubMed ID: 9694355
[TBL] [Abstract][Full Text] [Related]
14. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.
Natali PG; Nicotra MR; Bigotti A; Venturo I; Marcenaro L; Giacomini P; Russo C
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6719-23. PubMed ID: 2672003
[TBL] [Abstract][Full Text] [Related]
15. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
16. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
18. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
19. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
20. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
